A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2002
08/29/2002	US20020119923 Administering macrophage derived compound
08/29/2002	US20020119916 Emulsion; therapy, diagnosis
08/29/2002	US20020119912 Synergistic mixture; therapy for psychological disorders
08/29/2002	US20020119910 Drug delivery
08/29/2002	US20020119582 Signal enhancement of bispecific antibody-polymer probe for immunoassay use
08/29/2002	US20020119566 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
08/29/2002	US20020119517 Detection of modulators of body weight; obtain cell samples, monitor expression of preferenial genes, incubate with modulators, compare to control, monitor adjustment in body weight
08/29/2002	US20020119510 Enzymatic polypeptide for use in screening bactericides
08/29/2002	US20020119502 Screening drugs for use in the treatment of mammary gland cancer; obtain animal, inject or orally administer anticarcinogeneic agent, monitor animal for development of cancer
08/29/2002	US20020119443 Screening preferential prodrugs for use in viral therapy; obtain target tissue, incubate with prodrug, monitor and evaluate prodrug activity in tissues
08/29/2002	US20020119430 Hypnotist referral network
08/29/2002	US20020119307 Substrate with a photocatalytic coating
08/29/2002	US20020119216 Coated chewing gum products containing an antigas agent
08/29/2002	US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms
08/29/2002	US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions
08/29/2002	US20020119203 Preparing first phase comprising nucleophilic active agent, a polymer and solvent; combining with second phase in a static mixer to form emulsion; extracting solvent from the emulsion, thereby forming microparticles
08/29/2002	US20020119202 For therapy of cancer and other angiogenic-dependent diseases
08/29/2002	US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment
08/29/2002	US20020119197 For providing uniform dosing over a prolonged period following a single administration
08/29/2002	US20020119196 May be used to make chewable tablets or rapidly disintegrating tablets that conveniently may be administered without water
08/29/2002	US20020119194 Pharmaceutical forms for the oral administration of mesna
08/29/2002	US20020119193 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/29/2002	US20020119192 Controlled release formulations for oral administration
08/29/2002	US20020119191 Pharmaceutical or food composition for treatment or prevention of brain edema
08/29/2002	US20020119187 Useful to induce analgesia
08/29/2002	US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source
08/29/2002	US20020119185 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
08/29/2002	US20020119181 Nutritional composition made from conventional foods for mixing onsite in a blender and treating patients with hepatic disorders
08/29/2002	US20020119174 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
08/29/2002	US20020119172 Method for reducing the appearance of dark circles under the eyes
08/29/2002	US20020119168 Therapeutic agent delivery
08/29/2002	US20020119157 For cancer therapy
08/29/2002	US20020119150 Administering an effective amount of a CD40:CD154 binding interrupter to primate graft recipient for therapy of rejection of tissue graft
08/29/2002	US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents
08/29/2002	US20020119136 Antimicrobial peroxidase compositions
08/29/2002	US20020119122 Ribavirin-pegylated interferon alfa induction hcv combination therapy
08/29/2002	US20020119119 Administering natural killer cell activating cytokine or flavonoid, wherein cytokine is not IL-2 or IFN-alpha; administering histamine or serotonin or H2 receptor agonists to inhibit production or release of hydrogen peroxide
08/29/2002	US20020119117 Modulated release particles for aerosol delivery
08/29/2002	US20020119115 Nitric oxide-releasing medical devices
08/29/2002	US20020119114 Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures
08/29/2002	US20020119112 Use of a hair benefit agent as an ingredient in a topical hair treatment formulation for the purpose of targeting an active endogenous hair fibre enzyme when formulation is applied to the hair
08/29/2002	US20020119108 Antiperspirant products
08/29/2002	US20020119104 Treatment of mucositis
08/29/2002	US20020119103 Stability, uniformity
08/29/2002	US20020119095 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
08/29/2002	US20020117170 Compositions and methods for the pulmonary delivery of aerosolized macromolecules
08/29/2002	DE10164343A1 Tablettierfähige Zusammensetzung mit Natrium Fosinopril Tabletting flowing composition with fosinopril sodium
08/29/2002	DE10108387A1 Kosmetisches oder pharmazeutisches Mittel Cosmetic or pharmaceutical composition
08/29/2002	DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives
08/29/2002	DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
08/29/2002	DE10106971A1 Arzneimittelformulierung die einen muskarinischen Agonisten enthält Pharmaceutical formulation containing a muscarinic agonist
08/29/2002	DE10106970A1 Neues Benzoylguanidinsalz New Benzoylguanidinsalz
08/29/2002	DE10065478C1 Kreatin/Citronensäure-Verbindung, Verfahren zu ihrer Herstellung und Verwendung Creatine / citric acid combination, processes for their preparation and use
08/29/2002	CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
08/29/2002	CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy
08/29/2002	CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
08/29/2002	CA2439193A1 Casoase 3 inhibitors
08/29/2002	CA2438805A1 Fluoro oxindole derivatives as modulators of kcnq potassium channels
08/29/2002	CA2438769A1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
08/29/2002	CA2438750A1 Aminoglycoside treatment for lysosomal storage diseases
08/29/2002	CA2438711A1 Tryptase inhibitors
08/29/2002	CA2438709A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
08/29/2002	CA2438685A1 Tryptase inhibitors
08/29/2002	CA2438682A1 Antibodies that bind both bcma and taci
08/29/2002	CA2438650A1 Process for the preparation of citalopram
08/29/2002	CA2438610A1 Treatment of refractory tumors using epothilone derivatives
08/29/2002	CA2438598A1 Epothilone derivatives for the treatment of refractory tumors
08/29/2002	CA2438519A1 Emulsions and aqueous dispersions of phytosterols
08/29/2002	CA2438504A1 Treatment of solid tumours with rapamycin derivatives
08/29/2002	CA2438367A1 Thiophene substituted amine derivatives as glyt-1 inhibitors
08/29/2002	CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002	CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002	CA2438312A1 Anthrone derivatives and their use as jnk inhibitors
08/29/2002	CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002	CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil
08/29/2002	CA2438235A1 Neurotransmission-associated proteins
08/29/2002	CA2438231A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
08/29/2002	CA2437989A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
08/29/2002	CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/29/2002	CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
08/29/2002	CA2437242A1 Tramadol-based medicament
08/29/2002	CA2437168A1 Retinoid hepatitis therapy
08/29/2002	CA2436832A1 Crystal form of a cyclic depsipeptide having improved activity
08/29/2002	CA2435177A1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
08/29/2002	CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same
08/29/2002	CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
08/29/2002	CA2433866A1 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
08/29/2002	CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
08/29/2002	CA2432929A1 Antiviral method of use
08/29/2002	CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002	CA2426811A1 Novel formulations of carvedilol
08/29/2002	CA2411973A1 New phenylpiperazines
08/28/2002	EP1234876A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
08/28/2002	EP1234828A1 Agents for improving learning or memory
08/28/2002	EP1234816A1 Scyphostatin analogues as SMase inhibitors
08/28/2002	EP1234815A2 Crystalline choline ascorbate
08/28/2002	EP1234585A2 Methods and compositions for the prevention or treatment of cancer
08/28/2002	EP1234582A1 Concomitant drugs for treating glaucoma
08/28/2002	EP1234578A2 Antitumor and antiviral medications and method for producing the same
08/28/2002	EP1234577A1 Radioprotecting agent

1 ... 5727 5728 5729 5730 5731 5732 5733 5734 5735 5736 5737 5738 5739 5740 5741 5742 5743 5744 5745 5746 5747 ... 7860